osmapiR
osmapiR is the rare API client that tracks its server's wiki revision numbers in the changelog.
Comparison · Analytics
ggsurvfit vs pharmaverseadam
A side-by-side editorial comparison of ggsurvfit and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
ggsurvfit vs pharmaverseadam: at a glance
What is ggsurvfit?
ggsurvfit is in correctness-and-compatibility mode, not feature mode.
The package draws survival and cumulative-incidence curves on a ggplot2 grammar, with risk tables, p-values and quantile annotations. Recent releases are entirely fixes and upstream tracking: ggplot2 v4.0.0 compatibility in 2025, and a 2026 patch correcting a Gray-test p-value that could be reported for the wrong competing event.
What is pharmaverseadam?
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
ggsurvfit vs pharmaverseadam: editorial side-by-side
ggsurvfit
2.5ANALYTICS
ggsurvfit is in correctness-and-compatibility mode, not feature mode.
◆ Current state
The package draws survival and cumulative-incidence curves on a ggplot2 grammar, with risk tables, p-values and quantile annotations. Recent releases are entirely fixes and upstream tracking: ggplot2 v4.0.0 compatibility in 2025, and a 2026 patch correcting a Gray-test p-value that could be reported for the wrong competing event.
◆ Where it's heading
The feature surface settled around 1.0.0, when risk-table alignment was exported and colour and linetype defaults became configurable. Since then the work is keeping pace with survival, ggplot2 and tidycmprsk changes, and closing cases where the plotted curve and the annotation disagreed — the p-value matched by position rather than name, confidence limits swapped for multi-state models, quantiles read off a plateau.
◆ Prediction
Expect the next release to track upstream survival or ggplot2 changes rather than add plotting features; the CDISC censoring convention adopted in Surv_CNSR() suggests further alignment with clinical data standards is the likelier direction.
pharmaverseadam
0.0ANALYTICS
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
◆ Current state
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
◆ Where it's heading
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
◆ Prediction
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Alternatives to ggsurvfit and pharmaverseadam
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ggsurvfit or pharmaverseadam.
ymlthis
ymlthis retired itself, naming Quarto as the reason it no longer needs to exist.
forestly
forestly built an interactive safety review tool, then taught it to produce submission-ready RTF.
pkglite
pkglite's whole job is knowing which files in an R package are text — and it keeps getting better at guessing.
gMCPLite
gMCPLite exists to be gMCP without Java, and its releases guard that boundary rather than extend it.
typst-gather
Extracted from Quarto's CLI, typst-gather learned to explain a dependency tree before fetching it.
See all ggsurvfit alternatives → · See all pharmaverseadam alternatives →
Recent activity from ggsurvfit and pharmaverseadam
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 20d agoggsurvfitGray-test p-values matched to the plotted outcome by name
- 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
- 10mo agoggsurvfitggplot2 v4.0.0 compatibility and multi-state CI label fix
- 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
- 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
- 2y agopharmaverseadam1.0 declares the dataset collection stable
- 2y agoggsurvfitNegative follow-up times and a cloglog transformation
- 2y agoggsurvfitAesthetic defaults become switchable and alignment is exported
- 2y agopharmaverseadamFirst release of the ADaM dataset collection
- 2y agoggsurvfitConfidence limits corrected for monotonicity-reversing transforms
- 3y agoggsurvfitGlue syntax in risk tables and coxph model support
Frequently asked questions
What is the difference between ggsurvfit and pharmaverseadam?
They serve adjacent needs but don't currently overlap on shipped themes. ggsurvfit is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is ggsurvfit better than pharmaverseadam?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ggsurvfit is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to ggsurvfit?
Top ggsurvfit alternatives in Analytics are ranked by recent ship velocity. Browse the "ggsurvfit alternatives" section above for the current picks, or visit /alternatives/ggsurvfit for the full list with editorial commentary on each.
What are the best alternatives to pharmaverseadam?
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.